ARTICLE | Clinical News
Pralatrexate: Completed Phase IIa enrollment
July 13, 2009 7:00 AM UTC
Allos completed enrollment of 201 current/former cigarette smokers who have failed >=1 platinum-based chemotherapy in an international Phase IIb trial evaluating IV pralatrexate given on days 1 and 15...